Leading organizational efforts in developing our local and global external ecosystem engagement and development within nucleic acid based medicine and RNA therapeutics. Forming part of the leadership of Roche Innovation Center Copenhagen and RNA molecule Research in Roche Pharma Research and Early Development reporting to global HQ in Basel.

Heading team responsible for leadership of projects, portfolio and strategy in the RNA Molecule Research unit, reporting into Therapeutic Modalities, Roche HQ, Basel. Part of leadership of Roche Innovation Center Copenhagen the RNA Therapeutics center of excellence within antisense oligonucleotide technology in Roche Pharma Research and Early Development.

Based in the RNA Therapeutics center of excellence at Roche Innovation Center Copenhagen (RICC) reporting locally as well as to the Therapeutic Modalities (TMo) function in Basel HQ. I'm responsible for promoting, integrating and catalyzing drug discovery across the entire RNA Therapeutics Research portfolio covering all disease translational areas (DTAs) within Roche Pharma Research and Early Development (pRED).Interim leader for Discovery Biology department responsible for leadership and execution of RNA biology and in vitro pharmacology aspects in drug discovery projects

Build-up of new therapy area and leadership of a team of 20 dedicated scientists, technicians, PhD/MSc students and trainees with expertise in drug discovery and pharmacology of diabetes complications, including diabetic retinopathy and diabetic nephropathy.Main responsibilities:- Scientific leadership, people & project management and pharmacology expert - Strategic analysis and development of new therapy area within drug discovery- Build-up and development of pharmacology competencies and technologies in team- Delivery of in vivo/ex vivo PoC and MoA data for early discovery to late development projects - Leadership of scientific strategies for team deliveries - Establishment and management of external project activities - Target discovery: identification and evaluation of new drug targets- Mentor and challenge employees to perform and develop - Cross-organisational stakeholder managementMain achievements:- Successful re-organisation, competency build-up and leadership of team within new therapy area- High employee motivation and job satisfaction also during times of change - Delivery of conclusive in vivo/ex vivo PoC and MoA data on several discovery projects- Establishment and management of several CRO/KOL project collaborations- Management of cross-organisational next-generation-sequencing project for late-stage development projectSpecialities: Scientific Leadership, Drug Discovery & Development, People & Project Management, Pharmacology, Life Sciences, R&D

Leading a team of 14 scientists, technicians and students with expertise in drug discovery and pharmacology within autoimmune and inflammatory disease research.Main responsibilities:- Leading the design and implementation of scientific strategies for team project deliveries - Leading continued development of competencies and technologies in team focused on high quality models and assays (i.e. nephritis, colitis, humanized graft-vs-host disease and various immunization models) - Delivery of in vivo pharmacology PK/PD PoC and MoA data to support projects from early discovery to early development.- Identification and evaluation of novel biological target opportunities- Mentor and challenge employees to perform and develop - Cross-organisational stakeholder managementMain achievements:- Succesful operation of team with high employee motivation and job satisfaction - Key team contributions to lead selection and early clinical development projects.- Personal delivery of conclusive in vivo/ex vivo PoC and MoA data for several discovery projects - Team-implementation of next-generation-sequencing databank generation Specialities: Scientific Leadership, Drug Discovery & Development, People & Project Management, Pharmacology, Life Sciences, R&D

Senior research scientist, pharmacologist and project co-ordinator within autoimmune and inflammatory disease research.Main responsibilities:- Delivery of in vivo, ex vivo and in vitro PK/PD PoC and MoA data in projects from early discovery to early development.- Project co-ordination and scientific design of in vivo pharmacology strategies - Establishment and implementation of new models and assay to support portfolio - Daily supervision of 2-3 technicians, students and lab tech. trainees.Main achievements- Successful delivery of PK/PD PoC and MoA data from humanized mouse model in several research projects captured in patent applications and publications.- Establishment and execution of several in vitro assays incl.: T-B cell assays and osteoclast assays - Establishment and PoC of hydrodynamic gene delivery in mice. - Spearheading department cell sorting and next-gen sequencing-collaboration and implementation in projects.Specialities: Scientific Leadership - Drug Discovery & Development - Pharmacology - Project Management - Life Sciences - Immunology - R&D

Post doc within in vivo pharmacology of autoimmune and inflammatory disease research. Main responsibilities: - Establishment and implementation of new models and assay to support portfolio- Support research projects with in vivo, ex vivo and in vitro PoC and MoA data Main achievements:- Successful establishment and publication of humanized mouse model of graft-vs-host disease based on engraftment of human peripheral blood mononuclear cells in highly immunodeficient mice. Specialities: Drug Discovery & Development - Pharmacology - Scientific Leadership - Project Management - Life Sciences - R&D - Immunology

PhD thesis work within immunology and pharmacology: Studied the functional role of Interleukin-21 as a novel therapeutic in cancer immunotherapy and its endogenous role in tumor immunity. Specialities: Drug Discovery & Development - Pharmacology - Scientific Leadership & Project Management - Life Sciences - Immunology - R&D

Responsible for execution of in vivo pharmacology studies within cancer and cancer immunotherapy research projects.Specialities: Drug Discovery & Development - Scientific Leadership - Project Management - Pharmacology - Immunology - R&D - Life Sciences

Visiting scientist with Prof. Mark J Smyth, department of Cellular Immunology, studied the role of endogenous Interleukin-21 in tumor immunity - as part of Ph.D. thesisSpecialities: Drug Discovery & Development - Scientific Leadership - Project Management - Pharmacology - Immunology - R&D - Life Sciences